Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Adenovirus-Based p53 gene therapy in ovarian cancer
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adenovirus-Based p53 gene therapy in ovarian cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adenovirus
100%
Adenovirus Vector
100%
Cell Growth
25%
CMV Promoter
25%
Gene Therapy
25%
Genetic Abnormalities
25%
H358
50%
High-level Expression
25%
Homozygous Deletion
25%
Infected Cells
25%
Inhibition Assay
25%
Inhibitory Effect
25%
Lung Cancer Cell Lines
25%
Lysate
25%
Molecular Genetics
25%
Molecular Targets
25%
Multiplicity of Infection
25%
Mutant p53
25%
Ovarian Cancer
100%
Ovarian Cancer Cells
50%
P53 Gene
25%
P53 Gene Therapy
100%
P53 Protein
25%
P53 Tumor Suppressor Gene
25%
Reporter Gene
25%
Therapeutic Agents
25%
TP53 mutation
25%
Vector System
25%
Western Blot Analysis
50%
Wild-type p53
25%
Wild-type p53 Gene
25%
Wild-type p53 Protein
25%
β-Galactosidase (β-Gal)
75%
Medicine and Dentistry
Adenoviridae
100%
Adenovirus Vector
26%
Cancer Cell
6%
Cell Growth
6%
Cell Line
13%
Galactose
26%
Galactosidase
20%
Gene Therapy
100%
Infection
13%
Lung Cancer Cell Line
6%
Ovarian Cancer
100%
Ovarian Cancer Cell Line
6%
Promoter Region
6%
Protein P53
100%
Reporter Gene
6%
Therapeutic Agent
6%
Tumor Suppressor Gene
6%
Western Blotting
13%
Pharmacology, Toxicology and Pharmaceutical Science
Adenoviridae
100%
Adenovirus Vector
26%
Galactose
26%
Galactosidase
20%
Infection
13%
Lung Cancer
6%
Molecular Target
6%
Ovary Cancer
100%
Protein P53
100%
Tumor Suppressor Protein
6%
Western Blot
13%
Immunology and Microbiology
Adenoviridae
100%
Adenovirus Vector
26%
Cancer Cell
6%
Cell Growth
6%
Cell Line
13%
Cell Lysate
6%
Lung Cancer Cell Line
6%
Multiplicity of Infection
6%
Ovarian Cancer Cell Line
6%
P53
100%
Promoter Region
6%
Reporter Gene
6%
Tumor Suppressor Gene
6%
Western Blot
13%
Wild Type
20%